EHRA White Paper: knowledge gaps in arrhythmia management-status 2019.

Clinicians accept that there are many unknowns when we make diagnostic and therapeutic decisions. Acceptance of uncertainty is essential for the pursuit of the profession: bedside decisions must often be made on the basis of incomplete evidence. Over the years, physicians sometimes even do not realize anymore which the fundamental gaps in our knowledge are. As clinical scientists, however, we have to halt and consider what we do not know yet, and how we can move forward addressing those unknowns. The European Heart Rhythm Association (EHRA) believes that scanning the field of arrhythmia / cardiac electrophysiology to identify knowledge gaps which are not yet the subject of organized research, should be undertaken on a regular basis. Such a review (White Paper) should concentrate on research which is feasible, realistic, and clinically relevant, and should not deal with futuristic aspirations. It fits with the EHRA mission that these White Papers should be shared on a global basis in order to foster collaborative and needed research which will ultimately lead to better care for our patients. The present EHRA White Paper summarizes knowledge gaps in the management of atrial fibrillation, ventricular tachycardia/sudden death and heart failure.

[1]  A. Goette,et al.  Clinical importance of atrial cardiomyopathy. , 2019, International journal of cardiology.

[2]  D. Dobrev,et al.  Role of inflammatory signaling in atrial fibrillation. , 2019, International journal of cardiology.

[3]  P. Libby,et al.  Anti-Inflammatory Therapy With Canakinumab for the Prevention of Hospitalization for Heart Failure , 2019, Circulation.

[4]  A. Goette,et al.  Impact of dronedarone on the risk of myocardial infarction and stroke in atrial fibrillation patients followed in general practices in Germany. , 2019, International journal of cardiology.

[5]  G. Lip,et al.  Spontaneous conversion in patients with non‐valvular atrial fibrillation planned for electrical cardioversion: A subanalysis of the EdoxabaN versus warfarin in subjectS UndeRgoing cardiovErsion Of Atrial Fibrillation (ENSURE‐AF) trial , 2019, American heart journal.

[6]  S. Nattel,et al.  Postoperative atrial fibrillation: mechanisms, manifestations and management , 2019, Nature Reviews Cardiology.

[7]  E. Braunwald,et al.  Angiotensin–Neprilysin Inhibition in Acute Decompensated Heart Failure , 2019, The New England journal of medicine.

[8]  X. Wehrens,et al.  Atrial-Specific Gene Delivery Using an Adeno-Associated Viral Vector , 2019, Circulation research.

[9]  Asif Ahmed,et al.  Survival after cardiac resynchronization therapy: results from 50 084 implantations , 2018, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[10]  Corey L. Reynolds,et al.  Enhanced Cardiomyocyte NLRP3 Inflammasome Signaling Promotes Atrial Fibrillation , 2018, Circulation.

[11]  P. Lambiase,et al.  Temporal pattern/episode duration-based classification of atrial fibrillation as paroxysmal vs. persistent: is it time to develop a more integrated prognostic score to optimize management? , 2018, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[12]  K. Ellenbogen,et al.  Permanent His-bundle pacing: a systematic literature review and meta-analysis , 2018, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[13]  A. Goette,et al.  German Cardiac Society Working Group on Cellular Electrophysiology state-of-the-art paper: impact of molecular mechanisms on clinical arrhythmia management , 2018, Clinical Research in Cardiology.

[14]  R. Hawkins,et al.  Postoperative atrial fibrillation is associated with increased morbidity and resource utilization after left ventricular assist device placement , 2018, Journal of Thoracic and Cardiovascular Surgery.

[15]  Michael J Ackerman,et al.  2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. , 2018, Journal of the American College of Cardiology.

[16]  G. Boriani,et al.  Atrioventricular junction ablation in patients with atrial fibrillation treated with cardiac resynchronization therapy: positive impact on ventricular arrhythmias, implantable cardioverter‐defibrillator therapies and hospitalizations , 2018, European journal of heart failure.

[17]  D. Dobrev,et al.  Antiarrhythmic drugs for atrial fibrillation: Imminent impulses are emerging , 2018, International journal of cardiology. Heart & vasculature.

[18]  C. Torp‐Pedersen,et al.  Importance of beta-blocker dose in prevention of ventricular tachyarrhythmias, heart failure hospitalizations, and death in primary prevention implantable cardioverter-defibrillator recipients: a Danish nationwide cohort study , 2018, Europace.

[19]  F. Crea,et al.  Appropriate implantable cardioverter-defibrillator interventions in cardiac resynchronization therapy–defibrillator (CRT-D) patients undergoing device replacement: time to downgrade from CRT-D to CRT-pacemaker? Insights from real-world clinical practice in the DECODE CRT-D analysis , 2018, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[20]  P. Lambiase,et al.  Propensity score matched comparison of subcutaneous and transvenous implantable cardioverter-defibrillator therapy in the SIMPLE and EFFORTLESS studies , 2018, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[21]  M. Brignole,et al.  A randomized controlled trial of atrioventricular junction ablation and cardiac resynchronization therapy in patients with permanent atrial fibrillation and narrow QRS , 2018, European heart journal.

[22]  K. Ellenbogen,et al.  Long-term outcomes of His bundle pacing in patients with heart failure with left bundle branch block , 2018, Heart.

[23]  Jennifer Cook Middleton,et al.  Screening for Atrial Fibrillation With Electrocardiography: Evidence Report and Systematic Review for the US Preventive Services Task Force , 2018, JAMA.

[24]  A. Camm,et al.  The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation: executive summary. , 2018, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[25]  W. Stevenson,et al.  Management of Ventricular Arrhythmias and Sudden Cardiac Death Risk Associated With Cardiac Channelopathies. , 2018, JAMA cardiology.

[26]  J. Healey,et al.  Cardiac resynchronization is pro-arrhythmic in the absence of reverse ventricular remodelling: a systematic review and meta-analysis , 2018, Cardiovascular research.

[27]  S. Steinhubl,et al.  Effect of a Home-Based Wearable Continuous ECG Monitoring Patch on Detection of Undiagnosed Atrial Fibrillation: The mSToPS Randomized Clinical Trial , 2018, JAMA.

[28]  A. Goette,et al.  Integration of “omics” techniques: Dronedarone affects cardiac remodeling in the infarction border zone , 2018, Experimental biology and medicine.

[29]  G. Boriani,et al.  2018 EHRA expert consensus statement on lead extraction: recommendations on definitions, endpoints, research trial design, and data collection requirements for clinical scientific studies and registries endorsed by APHRS/HRS/LAHRS , 2018, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[30]  G. Hindricks,et al.  Cardiac resynchronization therapy in the ageing population - With or without an implantable defibrillator? , 2018, International journal of cardiology.

[31]  G. Hindricks,et al.  Cardiac resynchronization therapy in heart failure: is the defibrillator needed? , 2018, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[32]  K. Dickstein,et al.  Upgrades from a previous device compared to de novo cardiac resynchronization therapy in the European Society of Cardiology CRT Survey II , 2018, European journal of heart failure.

[33]  G. Doros,et al.  Features of atrial fibrillation in wild‐type transthyretin cardiac amyloidosis: a systematic review and clinical experience , 2018, ESC Heart Failure.

[34]  D. Scherr,et al.  Management of patients with ventricular arrhythmias and prevention of sudden cardiac death—translating guidelines into practice: results of the European Heart Rhythm Association survey , 2018, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[35]  G. Dandamudi,et al.  Clinical Outcomes of His Bundle Pacing Compared to Right Ventricular Pacing. , 2018, Journal of the American College of Cardiology.

[36]  J. Hummel,et al.  Leadless pacemaker implantation and concurrent atrioventricular junction ablation in patients with atrial fibrillation , 2018, Pacing and clinical electrophysiology : PACE.

[37]  A. Capucci,et al.  Factors influencing the use of subcutaneous or transvenous implantable cardioverter-defibrillators: results of the European Heart Rhythm Association prospective survey , 2018, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[38]  R. Tieleman,et al.  Screening for atrial fibrillation: a European Heart Rhythm Association (EHRA) consensus document endorsed by the Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLAECE) , 2018 .

[39]  M. Masuda,et al.  Left atrial low-voltage areas predict atrial fibrillation recurrence after catheter ablation in patients with paroxysmal atrial fibrillation. , 2018, International journal of cardiology.

[40]  G. Boriani,et al.  Clinically oriented device programming in bradycardia patients: part 2 (atrioventricular blocks and neurally mediated syncope). Proposals from AIAC (Italian Association of Arrhythmology and Cardiac Pacing) , 2018, Journal of cardiovascular medicine.

[41]  G. Boriani,et al.  Clinically oriented device programming in bradycardia patients: part 1 (sinus node disease). Proposals from AIAC (Italian Association of Arrhythmology and Cardiac Pacing) , 2018, Journal of cardiovascular medicine.

[42]  S. Nattel,et al.  Translational Challenges in Atrial Fibrillation , 2018, Circulation research.

[43]  E. Schwammenthal,et al.  Rationale and design of the EACVI AFib Echo Europe Registry for assessing relationships of echocardiographic parameters with clinical thrombo-embolic and bleeding risk profile in non-valvular atrial fibrillation. , 2018, European heart journal cardiovascular Imaging.

[44]  Yuehua Liu,et al.  Elevated Circulating Fibrocytes Is a Marker of Left Atrial Fibrosis and Recurrence of Persistent Atrial Fibrillation , 2018, Journal of the American Heart Association.

[45]  M. Dorobanțu,et al.  The role of pro‐fibrotic biomarkers in paroxysmal and persistent atrial fibrillation , 2018, Cytokine.

[46]  G. Breithardt,et al.  Integrating new approaches to atrial fibrillation management: the 6th AFNET/EHRA Consensus Conference , 2018, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[47]  R. Borrás,et al.  Multielectrode vs. point-by-point mapping for ventricular tachycardia substrate ablation: a randomized study , 2018, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[48]  Christopher R. Ellis,et al.  Prospective Randomized Evaluation of Implantable Cardioverter‐Defibrillator Programming in Patients With a Left Ventricular Assist Device , 2018, Journal of the American Heart Association.

[49]  D. Lin,et al.  Reversal of Pacing-Induced Cardiomyopathy Following Cardiac Resynchronization Therapy. , 2018, JACC. Clinical electrophysiology.

[50]  L. Jordaens,et al.  Catheter Ablation for Atrial Fibrillation with Heart Failure , 2018, The New England journal of medicine.

[51]  G. Lip,et al.  Relation of Stroke and Bleeding Risk Profiles to Efficacy and Safety of Edoxaban for Cardioversion of Atrial Fibrillation (from the EdoxabaN versus warfarin in subjectS UndeRgoing cardiovErsion of Atrial Fibrillation [ENSURE-AF] Study). , 2018, The American journal of cardiology.

[52]  Dhanunjaya R. Lakkireddy,et al.  Hemodynamic Support in Ventricular Tachycardia Ablation: An International VT Ablation Center Collaborative Group Study. , 2017, JACC. Clinical electrophysiology.

[53]  V. Jeevanandam,et al.  Characterization of Ventricular Tachycardia After Left Ventricular Assist Device Implantation as Destination Therapy: A Single-Center Ablation Experience. , 2017, JACC. Clinical electrophysiology.

[54]  P. Vijayaraman,et al.  Atrioventricular node ablation and His bundle pacing. , 2017, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[55]  D. Mancini,et al.  Implantable Cardioverter-Defibrillators in Patients With a Continuous-Flow Left Ventricular Assist Device: An Analysis of the INTERMACS Registry. , 2017, JACC. Heart failure.

[56]  H. Huikuri,et al.  Association of sST2 and hs-CRP levels with new-onset atrial fibrillation in coronary artery disease. , 2017, International journal of cardiology.

[57]  M. Shoda,et al.  2017 HRS expert consensus statement on cardiovascular implantable electronic device lead management and extraction. , 2017, Heart rhythm.

[58]  Y. Chun,et al.  Clinical Impact of Asymptomatic Presentation Status in Patients With Paroxysmal and Sustained Atrial Fibrillation: The Fushimi AF Registry , 2017, Chest.

[59]  D. Fitzmaurice,et al.  Improved risk stratification of patients with atrial fibrillation: an integrated GARFIELD-AF tool for the prediction of mortality, stroke and bleed in patients with and without anticoagulation , 2017, BMJ Open.

[60]  P. García-Pavía,et al.  Diagnóstico y tratamiento de la amiloidosis cardiaca por transtiretina. Progreso y esperanza. , 2017 .

[61]  S. Yusuf,et al.  A biomarker-based risk score to predict death in patients with atrial fibrillation: the ABC (age, biomarkers, clinical history) death risk score , 2017, European heart journal.

[62]  B. Merkely,et al.  De novo implantation vs. upgrade cardiac resynchronization therapy: a systematic review and meta-analysis , 2017, Heart Failure Reviews.

[63]  K. Ellenbogen,et al.  Permanent His-bundle pacing as an alternative to biventricular pacing for cardiac resynchronization therapy: A multicenter experience. , 2017, Heart rhythm.

[64]  G. Boriani,et al.  Atrial antitachycardia pacing and atrial remodeling: A substudy of the international, randomized MINERVA trial. , 2017, Heart rhythm.

[65]  M. Chung,et al.  2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation , 2017, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[66]  G. Lip,et al.  Device-detected subclinical atrial tachyarrhythmias: definition, implications and management-an European Heart Rhythm Association (EHRA) consensus document, endorsed by Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS) and Sociedad Latinoamericana de Estimulación Cardíaca y Elect , 2017, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[67]  B. Wilkoff,et al.  Compliant endovascular balloon reduces the lethality of superior vena cava tears during transvenous lead extractions. , 2017, Heart rhythm.

[68]  M. Haissaguerre,et al.  Electrical storm in the early phase of HeartMate® II device implantation: Incidence, risk factors and prognosis. , 2017, Archives of cardiovascular diseases.

[69]  A. Goette,et al.  CREM-transgene mice: An animal model of atrial fibrillation and thrombogenesis. , 2017, Thrombosis research.

[70]  S. Narayan,et al.  Spatial relationship of organized rotational and focal sources in human atrial fibrillation to autonomic ganglionated plexi. , 2017, International journal of cardiology.

[71]  Gerhard Hindricks,et al.  A Decade of Information on the Use of Cardiac Implantable Electronic Devices and Interventional Electrophysiological Procedures in the European Society of Cardiology Countries: 2017 Report from the European Heart Rhythm Association , 2017, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[72]  B. Norrving,et al.  Non-vitamin K oral anticoagulants are non-inferior for stroke prevention but cause fewer major bleedings than well-managed warfarin: A retrospective register study , 2017, PloS one.

[73]  G. Hindricks,et al.  Devices for management of sudden cardiac death: Successes, challenges and perspectives. , 2017, International Journal of Cardiology.

[74]  A. Adler,et al.  Mechanical Support With Impella During Malignant Arrhythmia Ablation: A Case Report on the Growing Trend in the Electrophysiology Laboratory. , 2017, A & A case reports.

[75]  Charles R Kerr,et al.  Progression of paroxysmal to persistent atrial fibrillation: 10-year follow-up in the Canadian Registry of Atrial Fibrillation. , 2017, Heart rhythm.

[76]  G. Boriani,et al.  1315Effectiveness of a reactive atrial antitachycardia pacing feature in patients with ICDs: A large database analysis , 2017 .

[77]  J. Goldberger,et al.  Sudden Cardiac Arrest Risk Assessment: Population Science and the Individual Risk Mandate , 2017, JAMA cardiology.

[78]  V. Reddy,et al.  Outcomes of Ventricular Tachycardia Ablation Using Percutaneous Left Ventricular Assist Devices , 2017, Circulation. Arrhythmia and electrophysiology.

[79]  D. Pennell,et al.  Association Between Midwall Late Gadolinium Enhancement and Sudden Cardiac Death in Patients With Dilated Cardiomyopathy and Mild and Moderate Left Ventricular Systolic Dysfunction , 2017 .

[80]  J. Morgan,et al.  Remote management of heart failure using implantable electronic devices , 2017, European heart journal.

[81]  G. Hindricks,et al.  Daily remote monitoring of implantable cardioverter-defibrillators: insights from the pooled patient-level data from three randomized controlled trials (IN-TIME, ECOST, TRUST) , 2017, European heart journal.

[82]  P. Kirchhof,et al.  Screening for Atrial Fibrillation: A Report of the AF-SCREEN International Collaboration , 2017, Circulation.

[83]  P. Neužil,et al.  Cardiac Resynchronization Therapy With Wireless Left Ventricular Endocardial Pacing: The SELECT-LV Study. , 2017, Journal of the American College of Cardiology.

[84]  S. Nattel,et al.  Controversies About Atrial Fibrillation Mechanisms: Aiming for Order in Chaos and Whether it Matters , 2017, Circulation research.

[85]  N. Verma,et al.  Permanent His bundle pacing at the time of atrioventricular node ablation: A 3-dimensional mapping approach , 2017, HeartRhythm case reports.

[86]  R. Tilz,et al.  Implantable cardioverter defibrillator use for primary prevention in ischaemic and non-ischaemic heart disease—indications in the post-DANISH trial era: results of the European Heart Rhythm Association survey , 2017, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[87]  K. Ellenbogen,et al.  Benefits of Permanent His Bundle Pacing Combined With Atrioventricular Node Ablation in Atrial Fibrillation Patients With Heart Failure With Both Preserved and Reduced Left Ventricular Ejection Fraction , 2017, Journal of the American Heart Association.

[88]  A. Auricchio,et al.  Inappropriate shocks in single-chamber and subcutaneous implantable cardioverter-defibrillators: a systematic review and meta-analysis , 2017, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[89]  A. Bouzeman,et al.  Variability in obstructive sleep apnea: Analysis of pacemaker-detected respiratory disturbances. , 2017, Heart rhythm.

[90]  P. Kowey,et al.  Results of a curtailed randomized controlled trial, evaluating the efficacy and safety of azimilide in patients with implantable cardioverter‐defibrillators: The SHIELD‐2 trial , 2017, American heart journal.

[91]  M. Gold,et al.  Performance of the subcutaneous implantable cardioverter-defibrillator in patients with a primary prevention indication with and without a reduced ejection fraction versus patients with a secondary prevention indication. , 2017, Heart rhythm.

[92]  Gene Kim,et al.  Atrial Arrhythmias and Electroanatomical Remodeling in Patients With Left Ventricular Assist Devices , 2017, Journal of the American Heart Association.

[93]  T. Weber,et al.  Cardiac gene therapy with adeno-associated virus-based vectors , 2017, Current opinion in cardiology.

[94]  J. Prutkin,et al.  Simultaneous atrioventricular node ablation and leadless pacemaker implantation☆☆☆ , 2017, HeartRhythm case reports.

[95]  B. Bettencourt,et al.  A Highly Durable RNAi Therapeutic Inhibitor of PCSK9 , 2017, The New England journal of medicine.

[96]  Angelo B. Biviano,et al.  Atrial Fibrillation in Patients With Left Ventricular Assist Devices: Incidence, Predictors, and Clinical Outcomes. , 2016, JACC. Clinical electrophysiology.

[97]  P. Sharma,et al.  His Bundle Pacing Or Biventricular Pacing For Cardiac Resynchronization Therapy In Heart Failure: Discovering New Methods For An Old Problem. , 2016, Journal of atrial fibrillation.

[98]  P. Lambiase,et al.  Efficacy and safety of ablation for people with non-paroxysmal atrial fibrillation. , 2016, The Cochrane database of systematic reviews.

[99]  P. Kirchhof,et al.  2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. , 2016, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[100]  Abhishek Sharma,et al.  The role of implantable cardioverter-defibrillators in patients with continuous flow left ventricular assist devices - A meta-analysis. , 2016, International journal of cardiology.

[101]  T. Rostock,et al.  Cardiac arrhythmias in patients with Danon disease , 2016, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[102]  A. Capucci,et al.  Clinically guided pacemaker choice and setting: pacemaker expert programming study , 2016, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[103]  P. Ponikowski,et al.  [2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure]. , 2016, Kardiologia polska.

[104]  I. Goldenberg,et al.  Morbidity and mortality with cardiac resynchronization therapy with pacing vs. with defibrillation in octogenarian patients in a real-world setting , 2016, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[105]  S. Nattel,et al.  Electrophysiological and molecular mechanisms of paroxysmal atrial fibrillation , 2016, Nature Reviews Cardiology.

[106]  K. Kario,et al.  Higher Risk of Ischemic Events in Secondary Prevention for Patients With Persistent Than Those With Paroxysmal Atrial Fibrillation , 2016, Stroke.

[107]  G. Lip,et al.  EHRA/HRS/APHRS/SOLAECE expert consensus on atrial cardiomyopathies: definition, characterization, and clinical implication. , 2016, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[108]  S. Niwano,et al.  Discrimination of Paroxysmal and Persistent Atrial Fibrillation in Patients With New-Onset Atrial Fibrillation. , 2016, International heart journal.

[109]  C. Antzelevitch,et al.  Atrial fibrillation in inherited cardiac channelopathies: From mechanisms to management. , 2016, Heart rhythm.

[110]  Michela Masè,et al.  Myocardial Fibrosis Assessment by LGE Is a Powerful Predictor of Ventricular Tachyarrhythmias in Ischemic and Nonischemic LV Dysfunction: A Meta-Analysis. , 2016, JACC. Cardiovascular imaging.

[111]  C. Israel,et al.  Optimal tachycardia programming in ICDs , 2016, Herzschrittmachertherapie + Elektrophysiologie.

[112]  Hans Eiskjær,et al.  Defibrillator Implantation in Patients with Nonischemic Systolic Heart Failure. , 2016, The New England journal of medicine.

[113]  A. Proclemer,et al.  Different impact of long-detection interval and anti-tachycardia pacing in reducing unnecessary shocks: data from the ADVANCE III trial , 2016, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[114]  Christophe Leclercq,et al.  ALternate Site Cardiac ResYNChronization (ALSYNC): a prospective and multicentre study of left ventricular endocardial pacing for cardiac resynchronization therapy. , 2016, European heart journal.

[115]  Hugh Calkins,et al.  Catheter ablation in patients with persistent atrial fibrillation , 2016, European heart journal.

[116]  Maxime Sermesant,et al.  Impact of New Technologies and Approaches for Post–Myocardial Infarction Ventricular Tachycardia Ablation During Long-Term Follow-Up , 2016, Circulation. Arrhythmia and electrophysiology.

[117]  A. Moss,et al.  Sustained clinical benefit of cardiac resynchronization therapy in non-LBBB patients with prolonged PR-interval: MADIT-CRT long-term follow-up , 2016, Clinical Research in Cardiology.

[118]  A. Curtis,et al.  Improvement in Clinical Outcomes With Biventricular Versus Right Ventricular Pacing: The BLOCK HF Study. , 2016, Journal of the American College of Cardiology.

[119]  John L Sapp,et al.  Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs. , 2016, The New England journal of medicine.

[120]  S. Pocock,et al.  Cryoballoon or Radiofrequency Ablation for Paroxysmal Atrial Fibrillation. , 2016, The New England journal of medicine.

[121]  J. Brachmann,et al.  German ablation registry: Cryoballoon vs. radiofrequency ablation in paroxysmal atrial fibrillation--One-year outcome data. , 2016, Heart rhythm.

[122]  S. Nattel,et al.  The value of basic research insights into atrial fibrillation mechanisms as a guide to therapeutic innovation: a critical analysis. , 2016, Cardiovascular research.

[123]  Ashok J. Shah,et al.  Persistent Atrial Fibrillation From the Onset: A Specific Subgroup of Patients With Biatrial Substrate Involvement and Poorer Clinical Outcome. , 2016, JACC. Clinical electrophysiology.

[124]  A. Moss,et al.  Relationship between age and inappropriate implantable cardioverter-defibrillator therapy in MADIT-RIT (Multicenter Automatic Defibrillator Implantation Trial-Reduce Inappropriate Therapy). , 2016, Heart rhythm.

[125]  L. Friberg,et al.  Catheter ablation for atrial fibrillation is associated with lower incidence of stroke and death: data from Swedish health registries. , 2016, European heart journal.

[126]  A. Capucci,et al.  Effect of fixed-rate vs. rate-RESPONSIve pacing on exercise capacity in patients with permanent, refractory atrial fibrillation and left ventricular dysfunction treated with atrioventricular junction aBLation and bivEntricular pacing (RESPONSIBLE): a prospective, multicentre, randomized, single-blin , 2016, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[127]  Kevin Vernooy,et al.  Feasibility and Acute Hemodynamic Effect of Left Ventricular Septal Pacing by Transvenous Approach Through the Interventricular Septum , 2016, Circulation. Arrhythmia and electrophysiology.

[128]  Claes Held,et al.  The ABC (age, biomarkers, clinical history) stroke risk score: a biomarker-based risk score for predicting stroke in atrial fibrillation , 2016, European heart journal.

[129]  C. Hasdemir Atrial arrhythmias in inherited arrhythmogenic disorders , 2016, Journal of arrhythmia.

[130]  Andrea Mazzanti,et al.  2015 ESC Guidelines for the Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death. , 2016, Revista espanola de cardiologia.

[131]  Jagmeet P. Singh,et al.  2015 HRS/EHRA/APHRS/SOLAECE expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing. , 2016, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[132]  Sanjiv M. Narayan,et al.  Mechanistically based mapping of human cardiac fibrillation , 2016, The Journal of physiology.

[133]  Sanghamitra Mohanty,et al.  Ablation of Stable VTs Versus Substrate Ablation in Ischemic Cardiomyopathy: The VISTA Randomized Multicenter Trial. , 2015, Journal of the American College of Cardiology.

[134]  D. Mehta,et al.  Atrial Fibrillation in Cardiac Sarcoidosis. , 2015, Journal of atrial fibrillation.

[135]  H. Lambert,et al.  Randomized, Controlled Trial of the Safety and Effectiveness of a Contact Force–Sensing Irrigated Catheter for Ablation of Paroxysmal Atrial Fibrillation: Results of the TactiCath Contact Force Ablation Catheter Study for Atrial Fibrillation (TOCCASTAR) Study , 2015, Circulation.

[136]  Akshay S. Desai,et al.  Effect of the angiotensin-receptor-neprilysin inhibitor LCZ696 compared with enalapril on mode of death in heart failure patients. , 2015, European heart journal.

[137]  G. Boriani,et al.  New-generation atrial antitachycardia pacing (Reactive ATP) is associated with reduced risk of persistent or permanent atrial fibrillation in patients with bradycardia: Results from the MINERVA randomized multicenter international trial. , 2015, Heart rhythm.

[138]  N. Freemantle,et al.  The natural history of atrial fibrillation in patients with permanent pacemakers: is atrial fibrillation a progressive disease? , 2015, Journal of Interventional Cardiac Electrophysiology.

[139]  G. Boriani,et al.  Validation of a simple risk stratification tool for patients implanted with Cardiac Resynchronization Therapy: the VALID‐CRT risk score , 2015, European journal of heart failure.

[140]  Prashanthan Sanders,et al.  Indices of bipolar complex fractionated atrial electrograms correlate poorly with each other and atrial fibrillation substrate complexity. , 2015, Heart rhythm.

[141]  Oliver R. Segal,et al.  Is There Still a Role for Complex Fractionated Atrial Electrogram Ablation in Addition to Pulmonary Vein Isolation in Patients With Paroxysmal and Persistent Atrial Fibrillation?: Meta-Analysis of 1415 Patients , 2015, Circulation. Arrhythmia and electrophysiology.

[142]  Giuseppe Boriani,et al.  Management of atrial fibrillation in bradyarrhythmias , 2015, Nature Reviews Cardiology.

[143]  G. Boriani,et al.  Effects of enhanced pacing modalities on health care resource utilization and costs in bradycardia patients: An analysis of the randomized MINERVA trial. , 2015, Heart rhythm.

[144]  J. Healey,et al.  A Systematic Review on the Progression of Paroxysmal to Persistent Atrial Fibrillation: Shedding New Light on the Effects of Catheter Ablation. , 2015, JACC. Clinical electrophysiology.

[145]  Prashanthan Sanders,et al.  Approaches to catheter ablation for persistent atrial fibrillation. , 2015, The New England journal of medicine.

[146]  B. Pavri,et al.  Impact of baseline PR interval on cardiac resynchronization therapy outcomes in patients with narrow QRS complexes: an analysis of the ReThinQ Trial , 2015, Journal of Interventional Cardiac Electrophysiology.

[147]  Mårten Rosenqvist,et al.  Mass Screening for Untreated Atrial Fibrillation: The STROKESTOP Study , 2015, Circulation.

[148]  Ziad F Issa,et al.  Long‐Term Follow‐Up in AV Junction Ablation via the SVC in Patients Undergoing Concurrent Device Implantation: A Single Center Experience , 2015, Pacing and clinical electrophysiology : PACE.

[149]  P. Kirchhof,et al.  Efficacy of β blockers in patients with heart failure plus atrial fibrillation: an individual-patient data meta-analysis , 2014, The Lancet.

[150]  C. Sticherling,et al.  Comparison of Different Approaches to Atrioventricular Junction Ablation and Pacemaker Implantation in Patients with Atrial Fibrillation , 2014, Pacing and clinical electrophysiology : PACE.

[151]  G. Breithardt,et al.  Higher risk of death and stroke in patients with persistent vs. paroxysmal atrial fibrillation: results from the ROCKET-AF Trial , 2014, European heart journal.

[152]  G. Hindricks,et al.  Implant-based multiparameter telemonitoring of patients with heart failure (IN-TIME): a randomised controlled trial , 2014, The Lancet.

[153]  Ashok J. Shah,et al.  Driver Domains in Persistent Atrial Fibrillation , 2014, Circulation.

[154]  C. Combescure,et al.  Management of recalled implantable cardioverter-defibrillator leads at generator replacement: a decision analysis model for Fidelis leads. , 2014, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[155]  A. Moss,et al.  PR Interval Identifies Clinical Response in Patients With Non–Left Bundle Branch Block: A Multicenter Automatic Defibrillator Implantation Trial–Cardiac Resynchronization Therapy Substudy , 2014, Circulation. Arrhythmia and electrophysiology.

[156]  Helmut Pürerfellner,et al.  Clinical classifications of atrial fibrillation poorly reflect its temporal persistence: insights from 1,195 patients continuously monitored with implantable devices. , 2014, Journal of the American College of Cardiology.

[157]  Stanley Nattel,et al.  Early management of atrial fibrillation to prevent cardiovascular complications. , 2014, European heart journal.

[158]  Angelo Auricchio,et al.  Feasibility, safety, and short-term outcome of leadless ultrasound-based endocardial left ventricular resynchronization in heart failure patients: results of the wireless stimulation endocardially for CRT (WiSE-CRT) study. , 2014, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[159]  P. Ridker,et al.  Predisposing Factors Associated With Development of Persistent Compared With Paroxysmal Atrial Fibrillation , 2014, Journal of the American Heart Association.

[160]  G. Boriani,et al.  Atrial antitachycardia pacing and managed ventricular pacing in bradycardia patients with paroxysmal or persistent atrial tachyarrhythmias: the MINERVA randomized multicentre international trial , 2014, European heart journal.

[161]  Niels Voigt,et al.  Cellular and Molecular Electrophysiology of Atrial Fibrillation Initiation, Maintenance, and Progression , 2014, Circulation research.

[162]  Dhanunjaya R. Lakkireddy,et al.  Periprocedural Stroke and Bleeding Complications in Patients undergoing Catheter Ablation of Atrial Fibrillation with Different Anticoagulation Management: Results from the "COMPARE" Randomized Trial , 2014 .

[163]  Michael F Swartz,et al.  Dominant Frequency Increase Rate Predicts Transition from Paroxysmal to Long-Term Persistent Atrial Fibrillation , 2014, Circulation.

[164]  R. Bai,et al.  Pacing or Ablation: Which Is Better for Paroxysmal Atrial Fibrillation‐Related Tachycardia‐Bradycardia Syndrome? , 2014, Pacing and clinical electrophysiology : PACE.

[165]  Alexander Parkhomenko,et al.  Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials , 2014, The Lancet.

[166]  C. Bertrand,et al.  Evaluation of Time Course and Predicting Factors of Progression of Paroxysmal or Persistent Atrial Fibrillation to Permanent Atrial Fibrillation , 2014, Pacing and clinical electrophysiology : PACE.

[167]  T. Uejima,et al.  Progression to the persistent form in asymptomatic paroxysmal atrial fibrillation. , 2014, Circulation journal : official journal of the Japanese Circulation Society.

[168]  D. Exner,et al.  Impact of Programming Strategies Aimed at Reducing Nonessential Implantable Cardioverter Defibrillator Therapies on Mortality: A Systematic Review and Meta-Analysis , 2014, Circulation. Arrhythmia and electrophysiology.

[169]  M. Gasparini Avoiding unnecessary aggressive ICD programming after MADIT-RIT and ADVANCE III trials. , 2014, Journal of the American College of Cardiology.

[170]  K. Zsebo,et al.  Long-Term Effects of AAV1/SERCA2a Gene Transfer in Patients With Severe Heart FailureNovelty and Significance , 2014 .

[171]  G. Boriani,et al.  Cardiac resynchronization therapy in patients with atrial fibrillation: the CERTIFY study (Cardiac Resynchronization Therapy in Atrial Fibrillation Patients Multinational Registry). , 2013, JACC. Heart failure.

[172]  A. Proclemer,et al.  Indication to cardioverter-defibrillator therapy and outcome in real world primary prevention. Data from the IRIDE [Italian registry of prophylactic implantation of defibrillators] study. , 2013, International journal of cardiology.

[173]  B. Gersh,et al.  Outcomes of apixaban vs. warfarin by type and duration of atrial fibrillation: results from the ARISTOTLE trial. , 2013, European heart journal.

[174]  G. Hindricks,et al.  Risk stratification after myocardial infarction: is left ventricular ejection fraction enough to prevent sudden cardiac death? , 2013, European heart journal.

[175]  N. Uriel,et al.  Ventricular arrhythmias and implantable cardioverter-defibrillator therapy in patients with continuous-flow left ventricular assist devices: need for primary prevention? , 2013, Journal of the American College of Cardiology.

[176]  W. Shen,et al.  Effect of pacing method on risk of sudden death after atrioventricular node ablation and pacemaker implantation in patients with atrial fibrillation. , 2013, Heart rhythm.

[177]  Julie Redfern,et al.  Screening to identify unknown atrial fibrillation , 2013, Thrombosis and Haemostasis.

[178]  Mårten Rosenqvist,et al.  Stepwise Screening of Atrial Fibrillation in a 75-Year-Old Population: Implications for Stroke Prevention , 2013, Circulation.

[179]  V. Reddy,et al.  Percutaneous Hemodynamic Support With Impella 2.5 During Scar-Related Ventricular Tachycardia Ablation (PERMIT 1) , 2013, Circulation. Arrhythmia and electrophysiology.

[180]  P. Kirchhof,et al.  A proposal for new clinical concepts in the management of atrial fibrillation. , 2012, American heart journal.

[181]  David Keane,et al.  2012 HRS/EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design. , 2012, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[182]  M Juhani Junttila,et al.  Sudden Cardiac Death Caused by Coronary Heart Disease , 2012, Circulation.

[183]  G. Lip,et al.  Antithrombotic Therapy for Atrial Fibrillation: CHEST Guideline and Expert Panel Report , 2012, Chest.

[184]  A. Goette,et al.  The impact of rapid atrial pacing on ADMA and endothelial NOS. , 2012, International journal of cardiology.

[185]  A. Capucci,et al.  Subclinical atrial fibrillation and the risk of stroke. , 2012, The New England journal of medicine.

[186]  Edward J Ciaccio,et al.  Differences in Repeating Patterns of Complex Fractionated Left Atrial Electrograms in Longstanding Persistent Atrial Fibrillation as Compared With Paroxysmal Atrial Fibrillation , 2011, Circulation. Arrhythmia and electrophysiology.

[187]  L. Stevenson,et al.  Wireless pulmonary artery haemodynamic monitoring in chronic heart failure: a randomised controlled trial , 2011, The Lancet.

[188]  M. Russo,et al.  Atrial biopsy evidence of Fabry disease causing lone atrial fibrillation , 2010, Heart.

[189]  J. Morgan,et al.  The evaluation of pulmonary vein isolation and wide-area left atrial ablation to treat atrial fibrillation in patients with implanted permanent pacemakers: the Previously Paced Pulmonary Vein Isolation Study , 2010, Heart.

[190]  Joshua J. E. Blauer,et al.  Left Atrial Strain and Strain Rate in Patients With Paroxysmal and Persistent Atrial Fibrillation: Relationship to Left Atrial Structural Remodeling Detected by Delayed-Enhancement MRI , 2010, Circulation. Cardiovascular imaging.

[191]  J. Seward,et al.  Infiltrative cardiovascular diseases: cardiomyopathies that look alike. , 2010, Journal of the American College of Cardiology.

[192]  William T. Abraham,et al.  Physician-Directed Patient Self-Management of Left Atrial Pressure in Advanced Chronic Heart Failure , 2010, Circulation.

[193]  Robby Nieuwlaat,et al.  Progression from paroxysmal to persistent atrial fibrillation clinical correlates and prognosis. , 2010, Journal of the American College of Cardiology.

[194]  Christopher E Hilker,et al.  Incidence of Newly Detected Atrial Arrhythmias via Implantable Devices in Patients With a History of Thromboembolic Events , 2010, Stroke.

[195]  Stephan Willems,et al.  Catheter ablation of stable ventricular tachycardia before defibrillator implantation in patients with coronary heart disease (VTACH): a multicentre randomised controlled trial , 2010, The Lancet.

[196]  V. Santinelli,et al.  New-onset atrial fibrillation as first clinical manifestation of latent Brugada syndrome: prevalence and clinical significance. , 2009, European heart journal.

[197]  Maria Grazia Bongiorni,et al.  Transvenous lead extraction: Heart Rhythm Society expert consensus on facilities, training, indications, and patient management: this document was endorsed by the American Heart Association (AHA). , 2009, Heart rhythm.

[198]  M. Malik,et al.  Improved Stratification of Autonomic Regulation for risk prediction in post-infarction patients with preserved left ventricular function (ISAR-Risk) , 2008, European heart journal.

[199]  K. Stolen,et al.  A Blended Sensor Restores Chronotropic Response More Favorably than an Accelerometer Alone in Pacemaker Patients: The LIFE Study Results , 2008, Pacing and clinical electrophysiology : PACE.

[200]  C. Israel,et al.  The MINERVA study design and rationale: a controlled randomized trial to assess the clinical benefit of minimizing ventricular pacing in pacemaker patients with atrial tachyarrhythmias. , 2008, American heart journal.

[201]  R. Mantovan,et al.  Radiofrequency ablation of drug-refractory atrial fibrillation: an observational study comparing 'ablate and pace' with pulmonary vein isolation. , 2008, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[202]  P. Vardas,et al.  Extracellular matrix alterations in patients with paroxysmal and persistent atrial fibrillation: biochemical assessment of collagen type-I turnover. , 2008, Journal of the American College of Cardiology.

[203]  Michael J Ackerman,et al.  Prevalence of early-onset atrial fibrillation in congenital long QT syndrome. , 2008, Heart rhythm.

[204]  C. Antzelevitch,et al.  Atrial fibrillation and Brugada syndrome. , 2008, Journal of the American College of Cardiology.

[205]  Dietmar Schmitz,et al.  Closed loop stimulation and accelerometer-based rate adaptation: results of the PROVIDE study. , 2008, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[206]  A. Goette,et al.  Electrophysiological effects of angiotensin II. Part I: signal transduction and basic electrophysiological mechanisms. , 2008, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[207]  A. Moss,et al.  Risk stratification for primary implantation of a cardioverter-defibrillator in patients with ischemic left ventricular dysfunction. , 2008, Journal of the American College of Cardiology.

[208]  Jeremy N Ruskin,et al.  Prophylactic catheter ablation for the prevention of defibrillator therapy. , 2007, The New England journal of medicine.

[209]  H. E. Lim,et al.  Wegener’s granulomatosis with progressive conduction disturbances and atrial fibrillation , 2007, Heart.

[210]  S. Priori,et al.  Diagnosis and treatment of catecholaminergic polymorphic ventricular tachycardia. , 2007, Heart rhythm.

[211]  A. Goette,et al.  Cigarette smoking induces atrial fibrosis in humans via nicotine , 2007, Heart.

[212]  C. Bailleul,et al.  Biventricular stimulation to prevent cardiac desynchronization: rationale, design, and endpoints of the 'Biventricular Pacing for Atrioventricular Block to Prevent Cardiac Desynchronization (BioPace)' study. , 2006, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[213]  P. Marino,et al.  Prevention of ventricular desynchronization by permanent para-Hisian pacing after atrioventricular node ablation in chronic atrial fibrillation: a crossover, blinded, randomized study versus apical right ventricular pacing. , 2006, Journal of the American College of Cardiology.

[214]  C. Tai,et al.  Catheter Ablation of Atrial Fibrillation Versus Atrioventricular Junction Ablation Plus Pacing Therapy for Elderly Patients with Medically Refractory Paroxysmal Atrial Fibrillation , 2005, Journal of cardiovascular electrophysiology.

[215]  H. Huikuri,et al.  Prediction of sudden cardiac death after acute myocardial infarction: role of Holter monitoring in the modern treatment era. , 2005, European heart journal.

[216]  Douglas L Packer,et al.  Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. , 2005, The New England journal of medicine.

[217]  D. DeMets,et al.  Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. , 2004, The New England journal of medicine.

[218]  A. Goette,et al.  Nonchannel drug targets in atrial fibrillation. , 2004, Pharmacology & therapeutics.

[219]  Y. Rudy,et al.  Noninvasive electrocardiographic imaging for cardiac electrophysiology and arrhythmia , 2004, Nature Medicine.

[220]  J. Cleland,et al.  Carvedilol alone or in combination with digoxin for the management of atrial fibrillation in patients with heart failure? , 2003, Journal of the American College of Cardiology.

[221]  Neil Sulke,et al.  Circadian variation of arrhythmia onset patterns in patients with persistent atrial fibrillation. , 2003, American heart journal.

[222]  C. Israel,et al.  Incremental programming of atrial anti-tachycardia pacing therapies in bradycardia-indicated patients: effects on therapy efficacy and atrial tachyarrhythmia burden. , 2003, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[223]  G. Breithardt,et al.  Prolonged Atrial Action Potential Durations and Polymorphic Atrial Tachyarrhythmias in Patients with Long QT Syndrome , 2003, Journal of cardiovascular electrophysiology.

[224]  D. Euler,et al.  The effect of atrial pacing therapies on atrial tachyarrhythmia burden and frequency: results of a randomized trial in patients with bradycardia and atrial tachyarrhythmias. , 2003, Journal of the American College of Cardiology.

[225]  B. Lüderitz,et al.  Advanced Pacemaker Diagnostic Features in the Characterization of Atrial Fibrillation: Impact on Preventive Pacing Algorithms , 2003, Pacing and clinical electrophysiology : PACE.

[226]  S. Hohnloser,et al.  Safety and efficacy of advanced atrial pacing therapies for atrial tachyarrhythmias in patients with a new implantable dual chamber cardioverter-defibrillator. , 2002, Journal of the American College of Cardiology.

[227]  C. Lau,et al.  Automatic Mode Switching of Implantable Pacemakers: I. Principles of Instrumentation, Clinical, and Hemodynamic Considerations , 2002, Pacing and clinical electrophysiology : PACE.

[228]  J. Oss,et al.  PROPHYLACTIC IMPLANTATION OF A DEFIBRILLATOR IN PATIENTS WITH MYOCARDIAL INFARCTION AND REDUCED EJECTION FRACTION , 2002 .

[229]  C W Israel,et al.  Pace‐Termination and Pacing for Prevention of Atrial Tachyarrhythmias: Results from a Multicenter Study with an Implantable Device for Atrial Therapy , 2001, Journal of cardiovascular electrophysiology.

[230]  G. Lip,et al.  Plasma von Willebrand factor, fibrinogen and soluble P-selectin levels in paroxysmal, persistent and permanent atrial fibrillation. Effects of cardioversion and return of left atrial function. , 2001, European heart journal.

[231]  E. Warman,et al.  Efficacy of Pacing Therapies for Treating Atrial Tachyarrhythmias in Patients With Ventricular Arrhythmias Receiving a Dual-Chamber Implantable Cardioverter Defibrillator , 2001, Circulation.

[232]  A. Goette,et al.  Expression and activity of ectopeptidases in fibrillating human atria. , 2001, Journal of molecular and cellular cardiology.

[233]  S. Connolly,et al.  Circadian variation of paroxysmal atrial fibrillation , 2001 .

[234]  A. Goette,et al.  Increased Expression of P‐Selectin in Patients with Chronic Atrial Fibrillation , 2000, Pacing and clinical electrophysiology : PACE.

[235]  A. Proclemer,et al.  Safety of Pacemaker Implantation Prior to Radiofrequency Ablation of Atrioventricular Junction in a Single Session Procedure , 2000, Pacing and clinical electrophysiology : PACE.

[236]  D. Casavant,et al.  Permanent, direct His-bundle pacing: a novel approach to cardiac pacing in patients with normal His-Purkinje activation. , 2000, Circulation.

[237]  S. Viskin,et al.  Circadian variation of symptomatic paroxysmal atrial fibrillation. Data from almost 10 000 episodes. , 1999, European heart journal.

[238]  J. Dartigues,et al.  Scoring Method for Assessing Rate Adaptive Pacemakers: Application to Two Different Activity Sensors , 1998, Pacing and clinical electrophysiology : PACE.

[239]  J. Brugada,et al.  Ventricular Fibrillation and Sudden Death After Radiofrequency Catheter Ablation of the Atrioventricular Junction , 1997, Pacing and clinical electrophysiology : PACE.

[240]  N Sulke,et al.  Dual Sensor VVIR Mode Pacing: Is It Worth It? , 1996, Pacing and clinical electrophysiology : PACE.

[241]  C. Lau,et al.  Rate adaptive pacing in sick sinus syndrome: effects of pacing modes and intrinsic conduction on physiological responses, arrhythmias, symptomatology and quality of life. , 1994, European heart journal.

[242]  D. Mcareavey,et al.  Radiofrequency Catheter Atrioventricular Node Ablation in Patients with Permanent Cardiac Pacing Systems , 1994, Pacing and clinical electrophysiology : PACE.

[243]  Jichao Zhao,et al.  Transient Rotor Activity During Prolonged 3-Dimensional Phase Mapping in Human Persistent Atrial Fibrillation. , 2018, JACC. Clinical electrophysiology.

[244]  James A. White,et al.  Late Gadolinium Enhancement and the Risk for Ventricular Arrhythmias or Sudden Death in Dilated Cardiomyopathy: Systematic Review and Meta-Analysis. , 2017, JACC. Heart failure.

[245]  M. Link,et al.  Stroke and Mortality Risk in Patients With Various Patterns of Atrial Fibrillation: Results From the ENGAGE AF-TIMI 48 Trial (Effective Anticoagulation With Factor Xa Next Generation in Atrial Fibrillation–Thrombolysis in Myocardial Infarction 48) , 2017, Circulation. Arrhythmia and electrophysiology.

[246]  G. Lip,et al.  Stroke prevention in atrial fibrillation: Past, present and future. , 2017, Thrombosis and haemostasis.

[247]  Volkmar Falk,et al.  2016 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure. , 2016, Revista espanola de cardiologia.

[248]  Kenneth A. Ellenbogen,et al.  The Ablate and Pace Trial: A Prospective Study of Catheter Ablation of the AV Conduction System and Permanent Pacemaker Implantation for Treatment of Atrial Fibrillation , 2004, Journal of Interventional Cardiac Electrophysiology.

[249]  M. Lupia,et al.  Reduction of complex ventricular arrhythmias after enalapril treatment in patients with advanced stable heart failure. , 1991, Giornale italiano di cardiologia.